In cancer research, GMMs are frequently used for tumor classification and patient stratification. By clustering patients based on their gene expression profiles or other biomarkers, researchers can identify distinct subgroups that may respond differently to treatments. This helps in developing personalized medicine approaches and improving outcomes.
